Reviewing the state of biotech with John Maraganore
- blonca9
- Dec 29, 2023
- 1 min read
John Maraganore shares his thoughts about biotech's big achievements in 2023, the financing environment, science, and hurdles to watch in 2024, HELIOS-B, and more.
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.